Numerous studies have been conducted in an attempt to uncover predictive biomarkers of response, which have so far been confined to PD-L1 expression,2 tumour mutational burden (TMB),3,4 tumour CD8+ T cell abundance, and DNA repair deficiencies.5 The gene discussed is CD8A; the disease is neoplasm.